Incretin drugs, diet, and exercise for weight loss
Part of Hormones & metabolism clinical trials.
This trial tests whether combining a new type of weight-loss medication with nutrition advice and physical activity helps people with obesity lose more weight. It’s for adults who are about to start an incretin-based drug for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been prescribed an incretin-based drug (like a GLP-1 or dual GIP/GLP1 agonist) but haven't started it yet.
- You have obesity (BMI over 30) or are overweight (BMI over 27) with a related condition like type 2 diabetes, high blood pressure, or high cholesterol.
- You do not have a medical condition that makes physical activity unsafe (for example, unstable heart disease or severe joint problems).
- You are not pregnant, breastfeeding, or planning a pregnancy during the study.
- You have not taken incretin-based drugs before and have not had bariatric surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different ways to keep weight off after you've lost weight using a GLP-1 medication, like semaglutide or tirzepatide. It tests reducing your GLP-1 dose and adding other weight loss medications to help maintain your progress.
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
This trial tests whether incretin-based diabetes medications (like GLP-1 drugs) can help people with a specific type of heart failure called HFpEF that is linked to obesity. The goal is to see if these drugs improve heart function and symptoms.
This study tests a new combination of two medicines, petrelintide and enicepatide, given as a shot to help with weight loss in people who are overweight or have obesity. The goal is to find the best dose and see if it works well and is safe.
This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.